U of A spinoff, U.S. firm merge to commercialize transplant technology
Bridge to Life commits US$10 million to clinical trial and commercial development of Tevosol Ex-Vivo Organ Support System
Read MoreBridge to Life commits US$10 million to clinical trial and commercial development of Tevosol Ex-Vivo Organ Support System
Read MorePlatform allows specialists to offer physiotherapy expertise for patients in smaller communities
Read MoreU of A scientists find that learning and past success play a role in how birds build their nests
Read MoreThe Islamist group has killed tens of thousands and displaced more than 2.3 million people since 2009
Read MorePromising results in mice open door to new areas of research in treating patients with heart failure
Read More